Similar articles

• Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.

  Frigui M, Hmida MB, Jallouli M, Kechaou M, Frikha F, Bahloul Z. Frigui M, et al. Saudi J Kidney Dis Transpl. 2010 Mar;21(2):320-2. Saudi J Kidney Dis Transpl. 2010. PMID: 20228521 Review.
• Membranous nephropathy: when and how to treat.

  Lai KN. Lai KN. Kidney Int. 2007 May;71(9):841-3. doi: 10.1038/sj.ki.5002201. Kidney Int. 2007. PMID: 17457329
• Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.

  Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC. Goumenos DS, et al. Am J Nephrol. 2007;27(3):226-31. doi: 10.1159/000101367. Epub 2007 Mar 27. Am J Nephrol. 2007. PMID: 17389782
• [The pharmacotherapy of chronic glomerulonephritis].

  Ratner MIa, Biriukova LS. Ratner MIa, et al. Klin Med (Mosk). 1992 Jan;70(1):114-9. Klin Med (Mosk). 1992. PMID: 1608196 Russian. No abstract available.
• [Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome].

  Saito T. Saito T. Nihon Jinzo Gakkai Shi. 2011;53(5):708-12. Nihon Jinzo Gakkai Shi. 2011. PMID: 21842605 Review. Japanese. No abstract available.